Platelet Aggregation Devices Market Size, Share & Trends Analysis Report By Product Type (Systems & Instruments, Consumables & Accessories), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
Platelet Aggregation Devices Market Growth & Trends
The global platelet aggregation devices market is expected to reach USD 1.18 billion by 2030 exhibiting a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing burden of chronic diseases such as heart disease and strokes. These conditions account for many global deaths, necessitating precise diagnostic and management tools. These devices are pivotal in assessing these conditions since platelet function is crucial in clot formation and blood vessel health.
Furthermore, advancements in healthcare technology have led to the development of more advanced and accurate platelet aggregation devices, meeting the growing demand for cutting-edge technology in the sector. For instance, in July 2022, Werfen launched GEMweb Live, an onscreen viewer for cardiac surgery test results, aiding in care decisions during cardiovascular procedures, with integration for platelet function monitoring. This digital solution can improve efficiency and guide clinical decisions during cardiovascular surgeries, potentially increasing the demand for platelet aggregation devices and related diagnostic tools in hospital acute care settings.
Healthcare policies and regulations further drive market growth when favorable while increasing awareness of disorders among healthcare professionals and the general population enhances the demand for these products. The prevalence of hereditary bleeding disorders such as hemophilia A, hemophilia B, and von Willebrand disease underscores the importance in managing such conditions effectively. Moreover, these devices play a crucial role in supporting critical clinical assessments and monitoring, which is contributing to the market's growth.
As healthcare systems continue to evolve and highlight the importance of accurate diagnostics and patient monitoring, the demand for platelet aggregation devices is on the rise. Additionally, the surge in R&D activities is driving innovation in platelet aggregation devices, making them increasingly relevant in modern healthcare. R&D efforts aim to enhance device sensitivity, specificity, and customization, allowing for more precise diagnostics across a wide range of health conditions.
Furthermore, platelet aggregation devices market players are undertaking strategic initiatives to address the growing demand for efficient and effective manufacturing capacity. Players are focusing on developing new products, clinical research, and innovation to strengthen their position. For instance, in June 2022, Sysmex America's XN-10 Automated Hematology Analyzer with Blood Bank mode received FDA clearance for residual white blood cell counting, a first in automated hematology analyzers. It provides efficient and accurate cell counts for blood component quality in transfusion medicine and blood product manufacturing. Such initiatives are expected to propel the overall growth of platelet aggregation devices market.
Platelet Aggregation Devices Market Report Highlights
- The consumables and accessories segment held the largest share in 2023 of the market and is anticipated to grow at the fastest growth rate over the forecast period
- The consumables & accessories segment dominated the market in 2023 owing to ongoing demand for reagents, test kits, and disposable components, driven by diagnostic and research needs in healthcare
- A few of the key players operating in the market include Siemens Healthcare GmbH, AggreDyne, Inc., Chrono-Log Corporation, Werfen, Bio/Data Corporation, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Haemonetics Corporation, Sienco, Inc., and Drucker Diagnostics.
- Based on end use, the market is segmented into hospitals, diagnostic centers, and research and academic institutes. The research and academic institutes segment held the largest share in 2023.
- North America has established a strong regional position in the market due to the presence of manufacturing facilities in the region.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End-use
- 1.3. Regional Scope
- 1.4. Estimates and Forecasts Timeline
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased database
- 1.6.2. GVR’s internal database
- 1.6.3. Secondary sources
- 1.6.4. Primary research
- 1.6.5. Details of Primary Research
- 1.6.5.1. Data for primary interviews in North America
- 1.6.5.2. Data for primary interviews in Europe
- 1.6.5.3. Data for primary interviews in Asia Pacific
- 1.6.5.4. Data for primary interviews in Latin America
- 1.6.5.5. Data for Primary interviews in MEA
- 1.7. Information or Data Analysis
- 1.7.1. Data analysis models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity flow analysis (Model 1)
- 1.9.2. Approach 1: Commodity flow approach
- 1.9.3. Volume price analysis (Model 2)
- 1.9.4. Approach 2: Volume price analysis
- 1.10. List of Secondary Sources
- 1.11. List of Primary Sources
- 1.12. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Trends and Outlook
- 3.4. Market Dynamics
- 3.4.1. Increasing prevalence of chronic conditions
- 3.4.2. Technological Advancement
- 3.4.3. Increasing R&D
- 3.5. Market Restraint Analysis
- 3.5.1. High Cost of Devices
- 3.6. Business Environment Analysis
- 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.6.2. Porter’s Five Forces Analysis
- Chapter 4. Product Type Business Analysis
- 4.1. Platelet Aggregation Devices Market: Product Type Movement Analysis
- 4.2. Systems and Instruments
- 4.2.1. Systems and Instruments Market, 2018 - 2030 (USD Million)
- 4.3. Consumables and Accessories
- 4.3.1. Consumables and Accessories Market, 2018 - 2030 (USD Million)
- Chapter 5. Application Business Analysis
- 5.1. Platelet Aggregation Devices Market: Site Movement Analysis
- 5.2. Clinical Applications
- 5.2.1. Clinical Applications Market, 2018 - 2030 (USD Million)
- 5.3. Research Applications
- 5.3.1. Research Applications Market, 2018 - 2030 (USD Million)
- Chapter 6. End-use Business Analysis
- 6.1. Platelet Aggregation Devices Market: End-use Movement Analysis
- 6.2. Hospital
- 6.2.1. Hospital Market, 2018 - 2030 (USD Million)
- 6.3. Diagnostic Centers
- 6.3.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
- 6.4. Research and Academic Institutes
- 6.4.1. Research and Academic Institutes Market, 2018 - 2030 (USD Million)
- Chapter 7. Regional Business Analysis
- 7.1. Platelet Aggregation Devices Market Share By Region, 2023 & 2030
- 7.2. North America
- 7.2.1. SWOT Analysis
- 7.2.2. North America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.2.3. U.S.
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Scenario
- 7.2.3.6. U.S. Platelet Aggregation Devices Market, 2018 - 2030 (USD MILLION)
- 7.2.4. Canada
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Target Disease Prevalence
- 7.2.4.3. Competitive Scenario
- 7.2.4.4. Regulatory Framework
- 7.2.4.5. Reimbursement Scenario
- 7.2.4.6. Canada Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. SWOT Analysis
- 7.3.2. Europe Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Scenario
- 7.3.3.6. Germany Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.4. UK
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Scenario
- 7.3.4.6. UK Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.5. France
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Scenario
- 7.3.5.6. France Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.6. Italy
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Scenario
- 7.3.6.6. Italy Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.7. Spain
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Spain Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.8. Denmark
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Scenario
- 7.3.8.6. Denmark Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.9. Sweden
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Scenario
- 7.3.9.6. Sweden Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.3.10. Norway
- 7.3.10.1. Key Country Dynamics
- 7.3.10.2. Target Disease Prevalence
- 7.3.10.3. Competitive Scenario
- 7.3.10.4. Regulatory Framework
- 7.3.10.5. Reimbursement Scenario
- 7.3.10.6. Norway Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. SWOT Analysis
- 7.4.2. Asia Pacific Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Scenario
- 7.4.3.6. Japan Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.4. China
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Scenario
- 7.4.4.6. China Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.5. India
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Scenario
- 7.4.5.6. India Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. South Korea Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.7. Australia
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Scenario
- 7.4.7.6. Australia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.4.8. Thailand
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Target Disease Prevalence
- 7.4.8.3. Competitive Scenario
- 7.4.8.4. Regulatory Framework
- 7.4.8.5. Reimbursement Scenario
- 7.4.8.6. Thailand Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. SWOT Analysis
- 7.5.2. Latin America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.5.3. Brazil
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Scenario
- 7.5.3.6. Brazil Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Regulatory Framework
- 7.5.4.5. Reimbursement Scenario
- 7.5.4.6. Mexico Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.5.5. Argentina
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Target Disease Prevalence
- 7.5.5.3. Competitive Scenario
- 7.5.5.4. Regulatory Framework
- 7.5.5.5. Reimbursement Scenario
- 7.5.5.6. Argentina Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.6. MEA
- 7.6.1. SWOT Analysis
- 7.6.2. MEA Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.6.3. South Africa
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Scenario
- 7.6.3.6. South Africa Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.6.4. Saudi Arabia
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Scenario
- 7.6.4.6. Saudi Arabia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.6.5. UAE
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Scenario
- 7.6.5.6. UAE Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- 7.6.6. Kuwait
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Target Disease Prevalence
- 7.6.6.3. Competitive Scenario
- 7.6.6.4. Regulatory Framework
- 7.6.6.5. Reimbursement Scenario
- 7.6.6.6. Kuwait Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.2.1. New Product Launch
- 8.2.2. Partnerships
- 8.2.3. Acquisition
- 8.2.4. Collaboration
- 8.2.5. Funding
- 8.3. Key Company Market Share Analysis, 2022
- 8.4. Company Heat Map Analysis
- 8.5. Company Profiles
- 8.5.1. . AGGREDYNE, INC.
- 8.5.1.1. Company Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. BIO/DATA CORPORATION
- 8.5.2.1. Company Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. CHRONO-LOG CORPORATION
- 8.5.3.1. Company Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. F. HOFFMANN-LA ROCHE LTD
- 8.5.4.1. Company Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. HAEMONETICS CORPORATION
- 8.5.5.1. Company Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. SIEMENS HEALTHCARE GMBH
- 8.5.6.1. Company Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. WERFEN
- 8.5.7.1. Financial Performance
- 8.5.7.2. Product Benchmarking
- 8.5.7.3. Strategic Initiatives
- 8.5.8. SYSMEX CORPORATION
- 8.5.8.1. Company Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. SIENCO, INC.
- 8.5.9.1. Financial Performance
- 8.5.9.2. Product Benchmarking
- 8.5.9.3. Strategic Initiatives
- 8.5.10. DRUCKER DIAGNOSTICS
- 8.5.10.1. Company Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook